Valneva, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in... View Article
Author Archives for Adeline Chauvigné
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine
11 May 2025Valneva, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in... View Article
New member | ClinGroup
ClinGroup is a full CRO of 6 Business Units providing Comprehensive Solutions For Health industry R&D; Established since 2002& Expanding... View Article
New member | ClinGroup
11 May 2025ClinGroup is a full CRO of 6 Business Units providing Comprehensive Solutions For Health industry R&D; Established since 2002& Expanding... View Article
New member | My-Serious-Game
Founded in 2014, My-Serious-Game is the French leader in custom-built digital learning solutions and a key European player: from analyzing... View Article
New member | My-Serious-Game
11 May 2025Founded in 2014, My-Serious-Game is the French leader in custom-built digital learning solutions and a key European player: from analyzing... View Article
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi®
Further Strengthens Global Intellectual Property Portfolio for Tedopi® in Non-Small Cell Lung Cancer until 2035 OSE Immunotherapeutics announced today that... View Article
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi®
11 May 2025Further Strengthens Global Intellectual Property Portfolio for Tedopi® in Non-Small Cell Lung Cancer until 2035 OSE Immunotherapeutics announced today that... View Article
Valneva: U.S. DoD Exercises First Year Option on IXIARO® Supply Contract
Valneva, a specialty vaccine company, today announced that the U.S. Department of Defense (DoD) has exercised the first option of... View Article
Valneva: U.S. DoD Exercises First Year Option on IXIARO® Supply Contract
11 May 2025Valneva, a specialty vaccine company, today announced that the U.S. Department of Defense (DoD) has exercised the first option of... View Article
New member | Centaur Clinical
Centaur Clinical (CC) is a CRO created in 2016 that conducts pre-clinical assays and clinical studies in Europe directly or... View Article
New member | Centaur Clinical
11 May 2025Centaur Clinical (CC) is a CRO created in 2016 that conducts pre-clinical assays and clinical studies in Europe directly or... View Article
OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
Clinical trial sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp.... View Article
OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
11 May 2025Clinical trial sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp.... View Article
Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S95011 Phase 2 Clinical Trial in Sjögren’s Syndrome
Servier, an independent global pharmaceutical group, and OSE Immunotherapeutics, a French biotech, have announced enrollment of the first patient... View Article
Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S95011 Phase 2 Clinical Trial in Sjögren’s Syndrome
11 May 2025Servier, an independent global pharmaceutical group, and OSE Immunotherapeutics, a French biotech, have announced enrollment of the first patient... View Article
New member | BioMAdvanced Diagnostics
BioMAdvanced Diagnostics aims to become a major player in biomarkers diagnostics, in France and internationally, starting with tests of immune... View Article
New member | BioMAdvanced Diagnostics
11 May 2025BioMAdvanced Diagnostics aims to become a major player in biomarkers diagnostics, in France and internationally, starting with tests of immune... View Article
Valneva commences rolling submission to MHRA for its inactivated, adjuvanted COVID-19 vaccine
Valneva, a specialty vaccine company focused on prophylactic vaccines for infectious diseases, today commenced rolling submission, for initial approval of... View Article
Valneva commences rolling submission to MHRA for its inactivated, adjuvanted COVID-19 vaccine
11 May 2025Valneva, a specialty vaccine company focused on prophylactic vaccines for infectious diseases, today commenced rolling submission, for initial approval of... View Article